Health Care

Health Care - Life Sciences Technology & Commercialization

Clinical Research and Clinical Trials

We understand the unique and complex challenges and protocols of clinical research and clinical trials. Stites & Harbison health care lawyers represent academic medical centers, teaching hospitals, universities and other institutions, as well as principle investigators. We counsel clients in the numerous standard agreements associated with clinical research (master service agreements, confidential disclosure agreements, material transfer agreements, federal and private contracts, grants, clinical and research service agreements, etc.), scientific integrity, scientific misconduct, privacy, human subject protection, and FDA reporting. Our clients also include biotechnology, life sciences, pharmaceutical and medical device companies.

We serve our clients in areas including:

Intellectual Property Protection Counseling

  • Patentability, freedom to operate, patent infringement, and patent validity analyses.
  • Preparation and prosecution of domestic and international patent applications.
  • Due diligence analysis including review and assessment of existing intellectual property portfolios.
  • Trademark availability analyses.
  • Preparation and prosecution of domestic and international trademark applications.
  • Domain name disputes resolution; domain name assignments and sales agreements.
  • Privacy policies and terms-of-use for commercial web sites.
  • Traditional and web site advertising review.

Enforcement of Intellectual Property Rights and Litigation:

  • Appeals to U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences
  • Defense and prosecution of patent infringement lawsuits and declaratory judgment actions in federal court
  • Defense and prosecution of trademark and copyright infringement lawsuits in federal court and before administrative bodies, including the USPTO Trademark Trial and Appeal Board and U.S. Copyright Office

Intellectual Property Licensing and Technology Transfer

  • Non-disclosure agreements and internal confidentiality policies
  • Review of co-branding, Internet, and traditional advertising agreements

Risk Management for Pharmaceutical, Biomedical, and Biotechnology product launch

Main Contact
See more related to Health Care - Life Sciences Technology & Commercialization
Press Releases

Stites & Harbison Expands Intellectual Property Practice with Addition of New Attorneys and Patent Agents

Stites & Harbison, PLLC is pleased to announce the addition of three attorneys and three patent agents to the firm’s Intellectual Property & Technology Service Group. All of the individuals join from one of the nation’s largest full-service intellectual property law firms. With the additions, Stites & Harbison will also be establishing a Hartford, Conn., office in the coming weeks.

by Stites & Harbison, PLLC September 12, 2024
Events

2024 Kentucky Health Law Institute

Date: 9/4/24 - 9/5/24

The Campbell House, 1375 South Broadway, Lexington, Kentucky

Stites & Harbison attorney Kelly Bryant is on the Planning Committee for the 2024 Kentucky Health Law Institute presented by UK Rosenberg College of Law. Healthcare attorney Shea Luna will be one of the speakers. The Institute is being held in Lexington, Kentucky September 4-5,

K. Kelly White Bryant and Stacy Shea Luna (Shea) July 11, 2024
Press Releases

Managing IP Honors Mandy Wilson Decker for 10th Time on 2024 “Top 250 Women in IP” List

Managing Intellectual Property (Managing IP) magazine recently selected Stites & Harbison, PLLC attorney Mandy Wilson Decker to the 2024 edition of Managing IP’s “Top 250 Women in IP.” This is the 10th time Decker has been honored on this list, and she is the only attorney honored from Kentucky.

by Stites & Harbison, PLLC July 09, 2024
Client Alerts

Providers and Laboratories Beware of EKRA: A Not-So-New Tool for Health Care Fraud and Abuse Enforcement

In an effort to combat the ongoing opioid crisis, Congress passed in 2018 the Eliminating Kickbacks in Recovery Act (“EKRA”) imposing significant monetary penalties on anyone paying or receiving payment for referrals to a recovery home, clinical treatment facility, or laboratory. However, given its broad language, EKRA may reach organizations not involved with substance abuse treatment. Health care providers and laboratories, therefore, should be aware of EKRA and its implications on their practice. Health care attorney Shea Luna takes a look at EKRA in this Stites & Harbison Client Alert.

by Stacy Shea Luna (Shea) June 07, 2024
Events

Kentucky Hospital Association Annual Convention

Date: 5/20/24 - 5/22/24

Central Bank Center, 430 West Vine Street, Lexington, Kentucky 40507

Health care attorneys Shea Luna and Sarah Spurlock will be presenters at the Kentucky Hospital Association's Annual Convention in Lexington, KY being held May 20-22, 2024.

Stacy Shea Luna (Shea) and Sarah Cronan Spurlock April 22, 2024